Eight Differential miRNAs in DN Identified by Microarray Analysis as Novel Biomarkers

Area of Science:

• Genomics
• Molecular Biology
• Biochemistry

Background:

• Diabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD) and chronic kidney disease (CKD).
• Current diagnostic and treatment methods for DN face prognostic challenges.
• Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), are increasingly recognized for their roles in disease pathogenesis and as potential biomarkers.

Purpose of the Study:

• To identify novel prognostic non-coding RNAs (ncRNAs) implicated in diabetic nephropathy (DN).
• To investigate the differential expression of miRNAs in DN and their interactions with key genes.
• To validate the expression levels of identified ncRNAs.

Main Methods:

• Bioinformatics analysis was employed to identify potential prognostic ncRNAs in DN.
• Differential expression analysis focused on miRNAs (DEmiRNAs) in DN.
• Quantitative polymerase chain reaction (qPCR) and the GEO database were used for expression level validation.
• A murine model was utilized for further validation of identified miRNAs.

Main Results:

• Eight specific upregulated DEmiRNAs were identified: miR-103a-2-5p, miR-297, miR-548x-3p, miR-604, miR-644a, miR-1256, miR-3911, and miR-5047.
• The expression levels of these miRNAs were further validated in a murine model of DN.
• The study identified a network of miRNA-gene interactions relevant to DN.

Conclusions:

• The identified upregulated DEmiRNAs represent potential novel biomarkers for DN.
• Elucidating the regulatory network of these miRNAs can enhance understanding of DN's molecular mechanisms.
• These findings suggest potential therapeutic targets for diabetic nephropathy.